Use of the polymerase chain reaction to specifically amplify integrated HPV-16 DNA by virtue of its linkage to interspersed repetitive DNA

被引:19
作者
Carmody, MW [1 ]
Jones, M [1 ]
Tarraza, H [1 ]
Vary, CPH [1 ]
机构
[1] MAINE MED CTR,RES INST,S PORTLAND,ME 04106
关键词
integration; nonradioisotopic probes; cervical carcinoma; Alu repeat;
D O I
10.1006/mcpr.1996.0015
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A polymerase chain reaction (PCR) based technique that combines a virus specific primer and a human interspersed repetitive sequence (IRS) specific primer in order to detect integration of human papilloma virus type 16 (HPV-16) is described. Amplification of viral-host DNA junctions occurs when viral integration results in placement of the virus specific primer binding site near (less that 3-4 kb) the primer binding site within a repetitive sequence element. The method relies on enzyme labeled oligonucleotide probes to achieve rapid, specific, and nonradioisotopic detection of viral integration related PCR products since episomal forms of the viral DNA do not lead to exponential accumulation of hybridizable PCR products. The technique is demonstrated for human genomic DNA derived from clinical cervical swab specimens and archival paraffin embedded blocks. Viral integration was detected in 41% of the HPV-16 positive samples (n = 34). In this positive subset, 64% were classified as invasive neoplasias, 29% CIN III and 7% CIN II. Analyzing the positive invasive neoplasias, 6 of 9 (66%) of the fingerprint results were obtained when an HPV primer was paired with an Alu primer. Interestingly, 100% of Alu primed fingerprint results obtained were derived from samples presenting invasive neoplasia (P<0.025 by chi square). (C) 1996 Academic Press Limited
引用
收藏
页码:107 / 116
页数:10
相关论文
共 36 条
[1]   IDENTIFICATION OF HUMAN PAPILLOMAVIRUS TYPE-18 TRANSFORMING GENES IN IMMORTALIZED AND PRIMARY-CELLS [J].
BEDELL, MA ;
JONES, KH ;
GROSSMAN, SR ;
LAIMINS, LA .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1247-1255
[2]  
CALLAHAN DE, 1991, CYTOMETRY, V13, P453
[3]  
CARMODY MW, 1993, BIOTECHNIQUES, V15, P692
[4]  
CARMODY MW, 1994, BIOTECHNIQUES, V16, P1044
[5]   LONG PCR [J].
CHENG, S ;
CHANG, SY ;
GRAVITT, P ;
RESPESS, R .
NATURE, 1994, 369 (6482) :684-685
[6]   HUMAN PAPILLOMAVIRUS TYPE-16 COOPERATES WITH ACTIVATED RAS AND FOS ONCOGENES IN THE HORMONE-DEPENDENT TRANSFORMATION OF PRIMARY MOUSE CELLS [J].
CROOK, T ;
STOREY, A ;
ALMOND, N ;
OSBORN, K ;
CRAWFORD, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :8820-8824
[7]  
DOEBERITZ MV, 1994, J VIROL, V68, P2811
[8]   A PCR APPROACH TO DISCRIMINATE BETWEEN INTEGRATED AND EPISOMAL HPV DNA IN SMALL CLINICAL SPECIMENS [J].
DONALDSON, YK ;
ARENDS, MJ ;
DUVALL, E ;
BIRD, CC .
MOLECULAR AND CELLULAR PROBES, 1993, 7 (04) :285-292
[9]   THE PHYSICAL STATE OF HUMAN PAPILLOMAVIRUS TYPE-16 DNA IN BENIGN AND MALIGNANT GENITAL TUMORS [J].
DURST, M ;
KLEINHEINZ, A ;
HOTZ, M ;
GISSMANN, L .
JOURNAL OF GENERAL VIROLOGY, 1985, 66 (JUL) :1515-1522
[10]   GLUCOCORTICOID-ENHANCED NEOPLASTIC TRANSFORMATION OF HUMAN KERATINOCYTES BY HUMAN PAPILLOMAVIRUS TYPE 16 AND AN ACTIVATED RAS ONCOGENE [J].
DURST, M ;
GALLAHAN, D ;
JAY, G ;
RHIM, JS .
VIROLOGY, 1989, 173 (02) :767-771